Jianqing Xu Selected Research

Jianqing Xu Research Topics

Disease

44	Infections 01/2022 - 03/2002
18	Human Influenza (Influenza) 01/2022 - 11/2006
17	Neoplasms (Cancer) 09/2022 - 09/2010
15	Vaccinia 08/2021 - 05/2003
14	COVID-19 02/2022 - 01/2020
8	Inflammation (Inflammations) 11/2021 - 01/2012
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 01/2005
5	Virus Diseases (Viral Diseases) 01/2021 - 01/2016
4	Persistent Infection 11/2017 - 01/2005
3	HIV Infections (HIV Infection) 09/2022 - 01/2018
3	Pneumonia (Pneumonitis) 11/2021 - 01/2014
3	Communicable Diseases (Infectious Diseases) 01/2021 - 09/2008
3	Tuberculosis (Tuberculoses) 12/2020 - 01/2015
3	Zika Virus Infection 01/2020 - 08/2017
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2014
2	Hypoxia (Hypoxemia) 10/2021 - 10/2020
2	Cough 01/2021 - 08/2020
2	Disease Progression 01/2021 - 02/2016
2	Astrocytoma (Pilocytic Astrocytoma) 01/2020 - 04/2014
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 02/2016
2	Influenza in Birds (Avian Flu) 09/2016 - 01/2012
2	Glioma (Gliomas) 04/2014 - 01/2014
1	Kidney Neoplasms (Kidney Cancer) 09/2022
1	Chronic Renal Insufficiency 07/2022
1	Insulin Resistance 07/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Bites and Stings (Sting) 01/2022
1	Spasm (Spasms) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Reinfection 01/2022

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 01/2022 - 01/2005
17	Proteins (Proteins, Gene)FDA Link 09/2022 - 05/2008
14	AntigensIBA 01/2022 - 05/2003
11	AntibodiesIBA 01/2022 - 01/2011
9	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2007
9	CytokinesIBA 11/2021 - 01/2014
7	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 11/2006
7	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2016
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2016
5	Immunoglobulin G (IgG)IBA 09/2022 - 12/2007
5	Neutralizing AntibodiesIBA 01/2022 - 11/2012
5	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 12/2013
5	Peptides (Polypeptides)IBA 01/2018 - 05/2003
5	DNA VaccinesIBA 12/2017 - 06/2007
4	Messenger RNA (mRNA)IBA 09/2022 - 01/2017
4	Interferon Type IIBA 01/2022 - 08/2017
4	Monoclonal AntibodiesIBA 10/2020 - 01/2017
4	EpitopesIBA 01/2020 - 05/2013
3	RNA (Ribonucleic Acid)IBA 09/2022 - 08/2017
3	EnzymesIBA 02/2022 - 01/2017
3	InterferonsIBA 01/2022 - 01/2014
3	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 10/2015
3	Chimeric Antigen ReceptorsIBA 10/2021 - 10/2020
3	Viral RNAIBA 01/2021 - 02/2014
3	Recombinant DNA (Recombinant DNA Research)IBA 01/2019 - 05/2014
2	LipopolysaccharidesIBA 09/2022 - 01/2017
2	ImmunosorbentsIBA 02/2022 - 01/2017
2	HymecromoneIBA 02/2022 - 01/2022
2	Hyaluronic Acid (Hyaluronan)IBA 02/2022 - 01/2022
2	Therapeutic UsesIBA 01/2022 - 06/2017
2	Glycoproteins (Glycoprotein)IBA 12/2021 - 01/2016
2	GP 140IBA 08/2021 - 06/2009
2	Biological ProductsIBA 05/2021 - 01/2015
2	InterleukinsIBA 01/2021 - 09/2015
2	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 05/2003
2	LigandsIBA 11/2020 - 06/2017
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 01/2018
2	Long Noncoding RNAIBA 01/2020 - 04/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 12/2007
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2017 - 06/2017
2	Anti-Infective Agents (Microbicides)IBA 02/2016 - 01/2012
2	Immunoglobulin A (IgA)IBA 01/2015 - 12/2007
2	DermaVirIBA 01/2005 - 01/2005
1	Kisspeptin-1 ReceptorsIBA 09/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022
1	Vitamin D FDA LinkGeneric 07/2022
1	fibrin fragment D (D-dimer)IBA 02/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Prescription DrugsIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2022
1	Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA 01/2022
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 12/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2021
1	Bovine Serum AlbuminIBA 06/2021
1	Adenovirus VaccinesIBA 06/2021

Therapy/Procedure

8	Immunotherapy 01/2022 - 01/2016
8	Therapeutics 01/2022 - 03/2002
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
1	Lasers (Laser) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021